Seeking Alpha

Biogen (BIIB +0.7%) moves up after Deutsche Bank says it conducted a survey and found that 40% -...

Biogen (BIIB +0.7%) moves up after Deutsche Bank says it conducted a survey and found that 40% - 57% of patients taking Baxter's (BAX +0.1%) Advate would consider switching to BIIB's new hemophilia treatment if the price was right.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs